ArticleFrontiers in neurology2018

Hippocampus and Insula Are Targets in Epileptic Patients With Glutamic Acid Decarboxylase Antibodies.

Mercè Falip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.